NCT02206243View on ClinicalTrials.gov

Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2018

Study Completion Date

February 28, 2019

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Embozene Microspheres

Intraarterial application

Trial Locations (1)

07740

Department of Radiology, University Hospital Jena, Jena

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Jena University Hospital

OTHER

NCT02206243 - Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter